154 related articles for article (PubMed ID: 38488482)
1. Correlation between morphological parameters and dosimetric parameters of the heart and spinal cord in the intermediate- and advanced-stage esophageal cancer.
Zhao W; Lan L; Xu B; Chen D; Zeng Y; Guo F; Zhang H
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2015. PubMed ID: 38488482
[TBL] [Abstract][Full Text] [Related]
2. Association between tumor morphology and dosimetric parameters of organs at risk after intensity-modulated radiotherapy in esophagus cancer.
Li F; Luo Y; Chen J; He L; Liang Y; Lai J; Guo F
J Appl Clin Med Phys; 2022 Jul; 23(7):e13612. PubMed ID: 35635800
[TBL] [Abstract][Full Text] [Related]
3. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric effect of intensity-modulated radiation therapy for postoperative non-small cell lung cancer with and without air cavity in the planning target volume.
Gan W; Duan Y; Wang H; Shao Y; Chen H; Feng A; Gu H; Huang Y; Ying Y; Fu X; Quan H; Xu Z
Med Dosim; 2022 Spring; 47(1):32-37. PubMed ID: 34551878
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
7. Applying the technique of volume-modulated arc radiotherapy to upper esophageal carcinoma.
Ma P; Wang X; Xu Y; Dai J; Wang L
J Appl Clin Med Phys; 2014 May; 15(3):4732. PubMed ID: 24892348
[TBL] [Abstract][Full Text] [Related]
8. [Dosimetric comparison of the helical tomotherapy, intensity-modulated radiotherapy and volumetric-modulated arc therapy in radical radiotherapy for esophageal cancer].
Xu YJ; Li P; Hu X; Wang J; Ma HL; Chen M
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3260-3265. PubMed ID: 31694123
[No Abstract] [Full Text] [Related]
9. Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study.
Zhang WZ; Chen JZ; Li DR; Chen ZJ; Guo H; Zhuang TT; Li DS; Zhou MZ; Chen CZ
World J Gastroenterol; 2014 Oct; 20(38):13973-80. PubMed ID: 25320535
[TBL] [Abstract][Full Text] [Related]
10. Is a clinical target volume (CTV) necessary for locally advanced non-small cell lung cancer treated with intensity-modulated radiotherapy? -a dosimetric evaluation of three different treatment plans.
Xia F; Zhou L; Yang X; Chu L; Zhang X; Chu J; Hu W; Zhu Z
J Thorac Dis; 2017 Dec; 9(12):5194-5202. PubMed ID: 29312726
[TBL] [Abstract][Full Text] [Related]
11. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
[TBL] [Abstract][Full Text] [Related]
12. The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET/CT guided in esophageal cancer.
Zhang Y; Fan B; Sun T; Xu J; Yin Y; Chen Z; Zhu J; Yu J; Hu M
J Cancer Res Ther; 2022 Sep; 18(5):1261-1267. PubMed ID: 36204871
[TBL] [Abstract][Full Text] [Related]
13. [Dosimetric comparison between intensity-modulated radiotherapy and conformal radiotherapy for upper thoracic esophageal carcinoma].
Zhang WZ; Chen ZJ; Li DR; Lin ZX; Li DS; Chen CZ
Ai Zheng; 2009 Nov; 28(11):1127-31. PubMed ID: 19895730
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma.
Zhang Y; Wang H; Huang X; Zhang Q; Ren R; Sun R; Zheng Z; Dong S; Zheng A
Med Dosim; 2019 Summer; 44(2):167-172. PubMed ID: 29950277
[TBL] [Abstract][Full Text] [Related]
15. DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer.
Münch S; Oechsner M; Combs SE; Habermehl D
Radiat Oncol; 2017 Aug; 12(1):128. PubMed ID: 28806990
[TBL] [Abstract][Full Text] [Related]
16. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison between Volumetric Modulated Arc Therapy (VMAT) vs Intensity Modulated Radiation Therapy (IMRT) for radiotherapy of mid esophageal carcinoma.
Kataria T; Govardhan HB; Gupta D; Mohanraj U; Bisht SS; Sambasivaselli R; Goyal S; Abhishek A; Srivatsava A; Pushpan L; Kumar V; Vikraman S
J Cancer Res Ther; 2014; 10(4):871-7. PubMed ID: 25579521
[TBL] [Abstract][Full Text] [Related]
18. Comparing treatment plan in all locations of esophageal cancer: volumetric modulated arc therapy versus intensity-modulated radiotherapy.
Lin JC; Tsai JT; Chang CC; Jen YM; Li MH; Liu WH
Medicine (Baltimore); 2015 May; 94(17):e750. PubMed ID: 25929910
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy.
Lin CY; Huang WY; Jen YM; Chen CM; Su YF; Chao HL; Lin CS
Dis Esophagus; 2014 Aug; 27(6):585-90. PubMed ID: 24134466
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
